Occupational Therapists in Woodhaven, MI Accepting Medicare
6 Occupational Therapists found. Showing 1 - 6
 Ryan Barbour Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18500 Van Horn Rd, Woodhaven, MI 48183 Phone: 734-676-7575 |
 Judith Lynn Briggs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 22750 Foxcroft St, Woodhaven, MI 48183 Phone: 734-934-5135 |
Maddison Maree Menna Occupational Therapist - Environmental Modification Medicare: Not Enrolled in Medicare Practice Location: 18500 Van Horn Rd, Woodhaven, MI 48183 Phone: 734-676-7575 |
Erika N Saunders, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 22315 King Rd, Woodhaven, MI 48183 Phone: 734-493-1680 Fax: 734-692-0804 |
Mackenzie R Mousouleas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21267 Mayfair St, Woodhaven, MI 48183 Phone: 734-672-2933 |
Sarah Elizabeth Miller, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 22196 Nelson St, Woodhaven, MI 48183 Phone: 734-925-0037 |
News Archive
Coal seam gas and cancer risk: Report
An Australian Senate committee has been looking into the impact of coal seam gas (CSG) mining on the Murray-Darling Basin that has moved to Dalby on Queensland's western Darling Downs today. The Senate Standing Committee on Rural Affairs and Transport is touring southern Queensland examining the environmental consequences of CSG mining on the Murray-Darling River system.
Researchers discover how Ras oncogene chooses a signaling pathway
The National Cancer Institute estimates that more than 43,000 Americans were diagnosed with pancreatic cancer last year and more than 36,000 died from the disease. Despite advances in genetic science showing that the Ras oncogene is mutated in virtually all pancreatic cancers, scientists have been frustrated by the complexity of the signaling pathways in humans, which make it difficult to pinpoint potential therapeutic targets.
Global initiative for reducing time taken to introduce new combination TB treatments
Ahead of World TB Day, US Food and Drug Administration Commissioner Margaret Hamburg helped public and private sector partners launch a new collaboration to significantly accelerate the development of combination treatments for tuberculosis — and replace an almost 50-year-old drug regimen. Created by the Global Alliance for TB Drug Development, the Critical Path Institute, and the Bill & Melinda Gates Foundation, the initiative could potentially reduce the time it takes to introduce new combination TB treatments from as much as a quarter century to as few as six years.
Salient Pharmaceuticals receives TETF commercialization award for CASAD therapy commercialization
Houston Technology Center (HTC), announced today that client company Salient Pharmaceuticals received a $2 million commercialization award from the Texas Emerging Technology Fund (TETF) for the commercialization of their CASAD therapy, an all natural product used to prevent and treat some cancer therapy-induced side effects.
› Verified 4 days ago
Physical Therapists
Optometrists
Occupational Therapists
Chiropractors
Podiatrists
Speech-Language Pathologists